Concepedia

Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium

Kathryn J. Fowler, Sudhakar K. Venkatesh, Nancy A. Obuchowski, Michael S. Middleton, Jun Chen, Kay Pepin, Jessica Magnuson, Kathy J Brown, Danielle Batakis, Walter C. Henderson,

Radiology · 2023 · 46 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

There is a need for reliable noninvasive methods for diagnosing and monitoring nonalcoholic fatty liver disease (NAFLD). Thus, the multidisciplinary Non-invasive Biomarkers of Metabolic Liver disease (NIMBLE) consortium was formed to identify and advance the regulatory qualification of NAFLD imaging biomarkers.

References

25

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Richard K. Sterling, Eduardo Lissen, Nathan Clumeck et al. · Hepatology · 2006 · 4.8K citations · Full text

, , +17

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

Mazen Noureddin, Jessica Lam, Michael R. Peterson et al. · Hepatology · 2013 · 544 citations · Full text

, , +16

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

Rohit Loomba, Tanya Wolfson, Brandon Ang et al. · Hepatology · 2014 · 477 citations

, , +17

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

Leonard B. Seeff, Gregory T. Everson, Timothy R. Morgan et al. · Clinical Gastroenterology and Hepatology · 2010 · 466 citations · Full text

, , +13

Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography

Donghee Kim, W. Ray Kim, Jayant A. Talwalkar et al. · Radiology · 2013 · 229 citations · Full text

, , +17